Searched for
MADHUSUDAN SARDA
Sun Pharma slips post Q4 results; brokerages slash target price, EPS estimatesSun Pharma plunged 10% in intraday trade, after the pharma major posted a consolidated net profit of Rs 888.05 cr.- PI Industries a safe bet among agri-based stocks: Madhusudan SardaThe company is dependent on domestic market and has a substantial presence in contract research and manufacturing services (CRAMS), says Sa...
- Good days ahead for oil marketing companies: Madhusudan SardaThe government has come out with diesel and LPG reforms, which is significantly ahead of what markets were expecting, feels Sarda.
- A lot of money could be made on Srikalahasthi Pipes: Madhusudan SardaThe company has been into Ductile iron (DI) pipes; it has been doing significantly well for last couple of years, says Sarda.
- PSU banks are headed for difficult times: Madhusudan SardaAs long as the commodity sectors do not do well, we are headed for difficult times in the PSU banking space.
- Sun Pharma in for some more pain in next few quarters: Madhusudan SardaSarda says that the way both Sun and Ranbaxy have structured themselves makes him believe that they should be able to integrate things 12 m...
Load More